Literature DB >> 22148077

Sporadic Creutzfeldt-Jakob disease: early signs and pre-mortem diagnosis.

Etienne Laverse1, Shahid Shah, Milica Mavra.   

Abstract

A 71-year-old Caucasian woman presented with a 3 week history of progressive ataxia followed by rapid cognitive decline. Examination on admission showed cerebellar ataxia. This was followed by multifocal dementia with cortical, subcortical and brainstem involvements during her hospital stay. Protein 14-3-3 was identified in the cerebrospinal fluid (CSF) as well as a markedly increased S100b. The patient was reviewed by the National CJD Surveillance Unit and the National Prion Unit who supported the pre-mortem diagnosis of probable Sporadic Creutzfeldt-Jakob disease. The patient deteriorated rapidly, became cortically blind, bed bound and died in May 2009, 4 months after the onset of symptoms.

Entities:  

Year:  2009        PMID: 22148077      PMCID: PMC3029590          DOI: 10.1136/bcr.07.2009.2105

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

1.  Progressive cognitive decline and myoclonus in a young woman: clinicopathological conference at the Edinburgh Advanced Neurology Course, 2007. Variant CJD. Subacute sclerosing panencephalitis.

Authors:  C A Heath; C Smith; R Davenport; G A Donnan
Journal:  Pract Neurol       Date:  2008-10

2.  Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease.

Authors:  I Zerr; M Bodemer; O Gefeller; M Otto; S Poser; J Wiltfang; O Windl; H A Kretzschmar; T Weber
Journal:  Ann Neurol       Date:  1998-01       Impact factor: 10.422

3.  14-3-3 {gamma}-isoform detection distinguishes sporadic Creutzfeldt-Jakob disease from other dementias.

Authors:  B R J Van Everbroeck; J Boons; P Cras
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-01       Impact factor: 10.154

4.  Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease.

Authors:  A J Green; E J Thompson; G E Stewart; M Zeidler; J M McKenzie; M A MacLeod; J W Ironside; R G Will; R S Knight
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-06       Impact factor: 10.154

Review 5.  Prospects for the development of pre-mortem laboratory diagnostic tests for Creutzfeldt-Jakob disease.

Authors:  Reza H Dabaghian; Philip P Mortimer; Jonathan P Clewley
Journal:  Rev Med Virol       Date:  2004 Nov-Dec       Impact factor: 6.989

6.  Enhanced geographically restricted surveillance simulates sporadic Creutzfeldt-Jakob disease cluster.

Authors:  Genevieve M Klug; Handan Wand; Alison Boyd; Matthew Law; Scott Whyte; John Kaldor; Colin L Masters; Steven Collins
Journal:  Brain       Date:  2008-11-28       Impact factor: 13.501

Review 7.  Neuroimaging findings in human prion disease.

Authors:  R G Macfarlane; S J Wroe; J Collinge; T A Yousry; H R Jäger
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11-29       Impact factor: 10.154

  7 in total
  1 in total

1.  Sporadic Creutzfeldt-Jakob disease with focal findings: caveats to current diagnostic criteria.

Authors:  Edward C Mader; Rima El-Abassi; Nicole R Villemarette-Pittman; Lenay Santana-Gould; Piotr W Olejniczak; John D England
Journal:  Neurol Int       Date:  2013-02-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.